Bengaluru, June 26 -- The shares of a leading mid-cap pharmaceutical company, known for its strong presence in API manufacturing, gained over 8 percent after the company announced the successful completion of a USFDA inspection at its Central Laboratory in Telangana with zero observations.

With a market capitalization of Rs 2,215 Crores, the share price of SMS Pharmaceuticals Ltd was trading almost 8% up to hit an intraday high of Rs 258.35 per share from its previous closing price of Rs 239.05 per share.

SMS Pharmaceuticals, in a stock exchange filing, said that the US FDA recently inspected its Central Laboratory Analytical Services in Gagillapur, Hyderabad, from June 23 to June 25, 2025. The inspection was completed with no issues or...